MASLD, or Metabolic Dysfunction-Associated Steatotic Liver Disease, affects 16-32% of India’s general population, impacting nearly 120 million people, with about 31% progressing to MASH. Recent studies using FibroScan reveal even higher rates, up to 68.2% prevalence nationwide, driven by urbanization, obesity, type 2 diabetes, insulin resistance, dyslipidemia, and metabolic syndrome. These intertwined factors amplify risks, […]
